Covering Disruptive Technology Powering Business in The Digital Age

Home > DTA news > BioXcel Celebrates 10th Anniversary as Leader of Big Data Revolution in Healthcare
BioXcel Celebrates 10th Anniversary as Leader of Big Data Revolution in Healthcare
February 22, 2016

GURGAON, India, BioXcel Corporation, a global leader in cloud-based big data platforms and developer of transformative patient treatments, and its Gurgaon-based subsidiary and Integrated Center of Xcellence, E.Z. BioXcel (EZB), today announced that they will celebrate their 10-year anniversary, on February 19, 2016. Established in 2006, EZB has built a robust, first-in-class big data platform, PharmGPS®, which has facilitated numerous strategic partnerships as well as an internal portfolio of drugs for orphan diseases and cancer.

Vimal Mehta, Ph.D., BioXcel’s Chairman and Chief Executive Officer, commented, “Our 10thanniversary marks a significant milestone for BioXcel. In the last decade, we have transformed from a promising startup idea into a next generation biotechnology company focused on improving patient lives through the application of big data analytics. We are grateful to all of our customers, partners, employees and investors for making this an incredible journey. As much as we have accomplished in our first ten years, we believe that our greatest accomplishments are yet to come. BioXcel will continue to deliver the highest levels of innovation and partnering success as we forge ahead.”

In addition to building strong relationships with its expanding list of customers and partners, BioXcel has experienced tremendous growth over the past 10 years. The EZB Center of Xcellence has been instrumental to BioXcel’s success, combining leading scientific and technical minds and cutting-edge technology to create a world-class ecosystem with the potential to drive a new paradigm in drug discovery and development. The company has grown to over 100 employees overseeing major research & development and operational needs.  BioXcel recently announced its expansion into CNS orphan disease therapeutics along with its plans to revolutionize cancer treatments using its big data immuno-oncology platform.

Krishnan Nandabalan, Ph.D., BioXcel’s President & Chief Scientific Officer, added, “We are thrilled to celebrate our decade long journey of learning, unlearning and pushing the big data envelope at every level. Today, we are at the intersection of big data and drug development, and are excited to see the results of our efforts in converting the power of pharma big data analytics into innovative medicines.”

To celebrate its 10th anniversary, the company will hold a grand event at the Westin, Gurgaon on Feb 19th2016 for its employees and well-wishers.

This article was originally published by globenewswire.com Post and can be viewed in full here

(0)(0)